These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 31511534)
1. E40, a novel microbial protease efficiently detoxifying gluten proteins, for the dietary management of gluten intolerance. Cavaletti L; Taravella A; Carrano L; Carenzi G; Sigurtà A; Solinas N; Caro S; Stasio LD; Picascia S; Laezza M; Troncone R; Gianfrani C; Mamone G Sci Rep; 2019 Sep; 9(1):13147. PubMed ID: 31511534 [TBL] [Abstract][Full Text] [Related]
2. E40 glutenase detoxification capabilities of residual gluten immunogenic peptides in Mamone G; Comelli MC; Vitale S; Di Stasio L; Kessler K; Mottola I; Siano F; Cavaletti L; Gianfrani C Front Nutr; 2022; 9():974771. PubMed ID: 36159465 [TBL] [Abstract][Full Text] [Related]
3. Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients. Tian N; Faller L; Leffler DA; Kelly CP; Hansen J; Bosch JA; Wei G; Paster BJ; Schuppan D; Helmerhorst EJ Appl Environ Microbiol; 2017 Mar; 83(6):. PubMed ID: 28087531 [TBL] [Abstract][Full Text] [Related]
4. Efficient Hydrolysis of Gluten-Derived Celiac Disease-Triggering Immunogenic Peptides by a Bacterial Serine Protease from Liu YY; Lee CC; Hsu JH; Leu WM; Meng M Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802942 [TBL] [Abstract][Full Text] [Related]
5. The human digestive tract has proteases capable of gluten hydrolysis. Gutiérrez S; Pérez-Andrés J; Martínez-Blanco H; Ferrero MA; Vaquero L; Vivas S; Casqueiro J; Rodríguez-Aparicio LB Mol Metab; 2017 Jul; 6(7):693-702. PubMed ID: 28702325 [TBL] [Abstract][Full Text] [Related]
6. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides. Moreno Amador ML; Arévalo-Rodríguez M; Durán EM; Martínez Reyes JC; Sousa Martín C PLoS One; 2019; 14(6):e0218346. PubMed ID: 31246975 [TBL] [Abstract][Full Text] [Related]
7. Selected Probiotic Lactobacilli Have the Capacity To Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion. Francavilla R; De Angelis M; Rizzello CG; Cavallo N; Dal Bello F; Gobbetti M Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500039 [TBL] [Abstract][Full Text] [Related]
8. Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease. Wei G; Tian N; Valery AC; Zhong Y; Schuppan D; Helmerhorst EJ Am J Gastroenterol; 2015 Jun; 110(6):899-908. PubMed ID: 25895519 [TBL] [Abstract][Full Text] [Related]
9. A food-grade enzyme preparation with modest gluten detoxification properties. Ehren J; Morón B; Martin E; Bethune MT; Gray GM; Khosla C PLoS One; 2009 Jul; 4(7):e6313. PubMed ID: 19621078 [TBL] [Abstract][Full Text] [Related]
10. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Stepniak D; Spaenij-Dekking L; Mitea C; Moester M; de Ru A; Baak-Pablo R; van Veelen P; Edens L; Koning F Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G621-9. PubMed ID: 16690904 [TBL] [Abstract][Full Text] [Related]
11. Development of wheat genotypes expressing a glutamine-specific endoprotease from barley and a prolyl endopeptidase from Flavobacterium meningosepticum or Pyrococcus furiosus as a potential remedy to celiac disease. Osorio CE; Wen N; Mejias JH; Liu B; Reinbothe S; von Wettstein D; Rustgi S Funct Integr Genomics; 2019 Jan; 19(1):123-136. PubMed ID: 30159724 [TBL] [Abstract][Full Text] [Related]
12. The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Tye-Din JA; Anderson RP; Ffrench RA; Brown GJ; Hodsman P; Siegel M; Botwick W; Shreeniwas R Clin Immunol; 2010 Mar; 134(3):289-95. PubMed ID: 19942485 [TBL] [Abstract][Full Text] [Related]
14. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427 [TBL] [Abstract][Full Text] [Related]
15. Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease. Pultz IS; Hill M; Vitanza JM; Wolf C; Saaby L; Liu T; Winkle P; Leffler DA Gastroenterology; 2021 Jul; 161(1):81-93.e3. PubMed ID: 33741317 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity. Helmerhorst EJ; Zamakhchari M; Schuppan D; Oppenheim FG PLoS One; 2010 Oct; 5(10):e13264. PubMed ID: 20948997 [TBL] [Abstract][Full Text] [Related]
17. Proteomic modelling of gluten digestion from a physiologically relevant food system: A focus on the digestion of immunogenic peptides from wheat implicated in celiac disease. Ogilvie O; Roberts S; Sutton K; Domigan L; Larsen N; Gerrard J; Demarais N Food Chem; 2020 Dec; 333():127466. PubMed ID: 32659668 [TBL] [Abstract][Full Text] [Related]
18. The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues. Pinier M; Fuhrmann G; Galipeau HJ; Rivard N; Murray JA; David CS; Drasarova H; Tuckova L; Leroux JC; Verdu EF Gastroenterology; 2012 Feb; 142(2):316-25.e1-12. PubMed ID: 22079593 [TBL] [Abstract][Full Text] [Related]
19. Gluten Degrading Enzymes for Treatment of Celiac Disease. Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754 [TBL] [Abstract][Full Text] [Related]
20. Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity. Caminero A; Galipeau HJ; McCarville JL; Johnston CW; Bernier SP; Russell AK; Jury J; Herran AR; Casqueiro J; Tye-Din JA; Surette MG; Magarvey NA; Schuppan D; Verdu EF Gastroenterology; 2016 Oct; 151(4):670-83. PubMed ID: 27373514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]